Global health official says outbreak of whooping cough in Texas, other states mirrors challenges in the developing world The outbreak of whooping cough in Texas, California, and other states this year underscores…
Tag: virus
Tamir’s compounds perform better than Ganciclovir for Cytomegalovirus disease
Tamir Biotechnology, Inc. (Pink Sheets: ACEL) (formerly Alfacell Corporation) announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) reported test results confirming two of our lead…
Entellus Medical announces Clinic versus OR study results for chronic sinusitis
Entellus Medical, a Minnesota-based medical technology company, shared the results of a 12-month study entitled “Clinic versus OR – A Comparative Analysis of Ostial Dilation for CRS,” presented on September 25th during…
Double-Balloon Enteroscopy shows successful results in pediatrics
The use of device-assisted enteroscopy, a technique that allows complete examination of the small bowel, may be just as successful pediatrics as it has been in adult medicine, according to a study…
Key pathway used by malaria parasite to infect human cells identified
Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The…
Did doctors jumpstart the HIV pandemic?
Perhaps it wasn’t sex workers and fast-growing cities that launched HIV onto its deadly global rampage, but well-meaning doctors using dirty needles in the first half of the 20th century. While it’s…
A Drug Against AIDS Could Be Effective Against The Herpesvirus
Scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by the coordinator of the Structural and Computational Biology Programme, Miquel Coll, have published a new study that demonstrates that raltegravir,…
Cerus receives $1.4 million to support development of INTERCEPT red blood cell system
Cerus Corporation (NASDAQ:CERS) announced today that it has received an additional $1.4 million from the U.S. Department of Defense to support advanced development of the company’s pathogen inactivation technology for red blood…
Legislation to help speed research for cystic fibrosis and other rare diseases
Today the U.S. House of Representatives passed the “Improving Access to Clinical Trials Act” (I-ACT), in a victory for the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations. The…
AJMS journal to update new infectious pathogens
Newly recognized disease-causing viruses, bacteria, and other infections are continually emerging around the world, posing difficult challenges for patient diagnosis and treatment and for public health responses. A special symposium section of…
FDA approves Roche’s COBAS AmpliPrep / COBAS TaqMan HBV Test v2.0
Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in…
CytoGenix initiates novel liner DNA technology testing on ferrets for vaccine development
CytoGenix, Inc. (Pink Sheets:CYGX) today announced that it has initiated the process of testing CytoGenix’s novel liner DNA technology on ferrets, with the expectations of a positive result, furthering the development of…
HIV cases predicted to rise
The NHS is braced for a sharp rise in patients seeking treatment for HIV, figures show. Estimates predict 70,000 patients will need HIV care this year, rising to 74,600 in 2011. That…
CDC, Epocrates educate healthcare professionals about safe injection practices
The Centers for Disease Control and Prevention (CDC) and Epocrates, Inc. are educating healthcare professionals about safe injection practices conveniently and effectively on their smartphone devices. Epocrates’ EssentialPoints® mobile detailing program provides…
Cranberry juice prevents urinary tract infections
Scientists reported new evidence on the effectiveness of that old folk remedy – cranberry juice – for urinary tract infections at the ACS’ 240th National Meeting. “A number of controlled clinical trials…